Although these late reports associate CREG1 functions with downstream signaling pathways, its tumor-suppressor-like functions might reside in its binding to the cation-independent mannose-6-phosphate insulin-like growth factor 2 receptor (M6P/IGF2R) [83]. The gene discussed is IGF2R; the disease is neoplasm.